Picture of KAKEN PHARMACEUTICAL logo

4521 — KAKEN PHARMACEUTICAL News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareConservativeMid CapNeutral

Table: Kaken Pharmaceutical -2024/25 div forecast

Aug 7 (Reuters) -
              Kaken Pharmaceutical Co Ltd     
              CONSOLIDATED EARNINGS ESTIMATES
     (in billions of yen unless specified)                    
                  Full year to      Full year to 
                Mar 31, 2025      Mar 31, 2025   
                   LATEST           PREVIOUS     
                  FORECAST          FORECAST     
  Annual Div     190.00 yen        150.00 yen    
  -Q2 Div        115.00 yen         75.00 yen    
  -Q4 Div         75.00 yen         75.00 yen    
   
  NOTE - Kaken Pharmaceutical Co Ltd.    
  If there is no Q1 or Q3 dividend, Q2 will in most cases correspond to the first-half 
  dividend and Q4 to the second-half dividend announced before a new corporate law in 2006 
  allowed companies to pay and report dividends on a quarterly basis.
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4521.T

Recent news on KAKEN PHARMACEUTICAL

See all news